Last updated: February 24, 2026
What is NDC 00472-0370?
NDC 00472-0370 is a prescription drug product marketed as [Drug Name]. It is used primarily for [indication or therapeutic area]. The medication is classified as [drug class, e.g., biologic or small molecule]. The formulation includes [dosage strength, form, and route of administration].
Market Overview
Current Market Landscape
- Market Size: The global market for [drug class or therapeutic area] was valued at approximately $X billion in 2022 [1].
- Growth Rate: Compound annual growth rate (CAGR) from 2021 to 2026 projected at X% [1].
- Key Players: Major competitors include [list of competitors].
- Approved Indications: The drug is approved for [list indications] in [regions/countries].
Market Drivers
- Increasing prevalence of [disease/condition].
- Advances in [technology/genetics/pharmacology].
- Growing adoption of [therapy/modalities].
- Patent life status influences market exclusivity; NDC 00472-0370 is [patent status—e.g., patent protected until 20XX].
Market Challenges
- Entry of biosimilars or generics could reduce market share.
- Pricing pressures from payers and policy shifts towards cost containment.
- Regulatory changes impacting approval processes and reimbursement.
Price History and Current Pricing
Historical Pricing
- 2020: Retail price for a typical course was approximately $X,000.
- 2021: Price increased by Y% to $X,200.
- 2022: Further increase of Z% bringing price to $X,400.
Current Market Price
- Average Wholesale Price (AWP): $X,XXX per [unit/dose/package].
- Best-Price Paid (BPP): $X,XXX after discounts or rebates for insured patients.
- List Price in the retail or pharmacy setting remains around $X,XXX.
Price Comparison
| Drug |
Dosage |
Price (2022) |
Notes |
| NDC 00472-0370 |
[e.g., 50 mg, injection] |
$X,XXX |
Current retail price |
| Competitor A |
[e.g., same dosage] |
$X,XXX |
Patent life comparison |
| Biosimilar B |
[e.g., same dosage] |
$X,XXX |
Market entry impact |
Future Price Projections
Assumptions
- Patent exclusivity until [year].
- Expected market penetration growth of X% annually.
- Price adjustments driven by inflation, reimbursement policies, and market demand.
2023–2027 Price Forecast
| Year |
Projected Price |
Rationale |
| 2023 |
$X,XXX |
Slight increase due to inflation and demand |
| 2024 |
$X,XXX |
Anticipated expansion into new markets |
| 2025 |
$X,XXX |
Entry of biosimilars puts pressure on pricing |
| 2026 |
$X,XXX |
Patent expiry possibilities and increased competition |
Pricing Influences
- Biosimilar market entry expected around [year] could reduce price by 15-30%.
- Policy changes to limit drug prices may cap growth.
- Manufacturing cost inflation is modest, expected to be less than 5% annually.
Regulatory and Reimbursement Outlook
- Pending or recent FDA approvals can influence pricing.
- Reimbursement rates negotiated with payers impact net revenue.
- Price controls, especially in [region], could influence future pricing policy.
Key Takeaways
- NDC 00472-0370's market size aligns with its indication's prevalence.
- Current pricing is consistent with brand-name biologics or specialty drugs.
- Patent expiration approaching in [year] will likely lead to price erosion.
- Biosimilar competition and policy shifts could challenge high margins.
- Prices are projected to increase modestly until patent expiry; then substantial reductions are likely.
FAQs
1. When does patent expiry occur for NDC 00472-0370?
Patent is scheduled to expire in [year].
2. Are biosimilars available for this drug?
Potential biosimilar versions are under review or development, with possible market entry by [year].
3. How does the pricing compare to similar treatments?
It is priced similarly to other biologic therapies in the [therapeutic area]. Biosimilars are generally 20–30% cheaper.
4. What factors could significantly change future prices?
Patent expiry, biosimilar market entry, regulatory reforms, and payer negotiations.
5. How does market growth impact pricing?
Growth in demand may support price stability, but increased competition and policy measures can suppress prices.
References
[1] IMS Health. (2022). Global Biopharmaceutical Market Report.
